How did Boston Scientific get its mojo back?

Nov 21, 2024 · The Boston Globe Its stock is up 50 percent. Billion-dollar deals for breakfast. How did Boston Scientific get its mojo back? “It’s been a brick by brick, constant improvement, …

9%
OFF

What's Behind The 2x Rise In Boston Scientific Stock?

2 weeks from now

Sep 11, 2024 · Not only did Boston Scientific post solid sales growth, but its profitability has also improved lately. Its operating margin expanded from 6.9% in 2020 to 17% in 2023, and further …

nasdaq.com

50%
OFF

STAT+: Buoyed By Billion-dollar Deals, Its Stock Is Up 50% This Year ...

2 weeks from now

Nov 13, 2024 · This might be surprising considering the damage caused by its bet-the-farm, $27 billion deal in 2006 for pacemaker company Guidant, which sealed a victory in its bidding war …

mwbn.bio

9%
OFF

What Drove A Nearly 2x Rise In Boston Scientific’s Profits? - Forbes

2 weeks from now

May 22, 2024 · Similarly, Boston Scientific also saw its operating margin expand from 6.9% in 2020 to 17% in 2023, and further to 17.2% for the last twelve months period. Although the …

forbes.com

145%
OFF

What Drove A Nearly 2x Rise In Boston Scientific's Profits?

2 weeks from now

May 23, 2024 · Boston Scientific saw its net income expand by $0.9 billion or 145% y-o-y to $1.6 billion in 2023. This can primarily be attributed to an expansion of its operating margin and …

nasdaq.com

50%
OFF

其股价上涨了 50%，波士顿科学公司是如何恢复活力的？

2 weeks from now

Nov 18, 2024 · How did Boston Scientific get its mojo back? By Jon Chesto Globe Staff,Updated November 12, 2024 . The entrance to the Boston Scientific campus in Marlborough. The …

su-innovationtimes.com

FAQs about How did Boston Scientific get its mojo back? Coupon?

Why did Boston Scientific lose a $27 billion deal with Johnson & Johnson?

This might be surprising considering the damage caused by its bet-the-farm, $27 billion deal in 2006 for pacemaker company Guidant, which sealed a victory in its bidding war against the larger Johnson & Johnson. That infamous merger saddled Boston Scientific with billions in debt and liabilities related to problems with Guidant’s devices. ...

What's behind Boston Scientific's Success?

One of those behemoths is the 25-year-old Boston Scientific, which had sales of $3.5 billion in 2003 and is expected to exceed that in 2004. Behind the success is the company's U.S. launch of its Taxus drug-eluting stent, a revolutionary technology that is radically changing the cardiovascular field. ...

How does Boston Scientific reinvest its money?

Boston Scientific developed a system: Set aside 10 percent of revenue for research and development, including to advance already acquired technologies, and devote much of its profits to new deals. “Pretty much every dollar that the company earns, we reinvest back into internal R&D and technology acquisition,” Butcher said. ...

How did Boston Scientific perform in 2023?

Not only did Boston Scientific post solid sales growth, but its profitability has also improved lately. Its operating margin expanded from 6.9% in 2020 to 17% in 2023, and further to 17.9% for the last twelve months period. ...

What's going on with Boston Scientific's stock in Marlborough?

For now, though, the story out of Marlborough remains focused on relentless growth: Revenue is expected to rise this year by 16.5 percent, clearing $16 billion. And with surging demand for two of its devices to treat atrial fibrillation, Boston Scientific’s stock has been on fire — posting a 50-plus percent increase this year alone. ...

Why did Boston Scientific merge with Guidant?

That infamous merger saddled Boston Scientific with billions in debt and liabilities related to problems with Guidant’s devices. A guide through the most important stories of the morning, delivered Monday, Wednesday, and Friday. Boston Scientific has become a big deal-maker under chief executive Mike Mahoney. ...